SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Liabilities | ₹333 Cr | ₹514 Cr | ₹830 Cr |
What is the latest Total Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹333 Cr |
| Mar2024 | ₹514 Cr |
| Mar2023 | ₹830 Cr |
How is Total Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹333 Cr | -35.14 | |
| Mar2024 | ₹514 Cr | -38.11 | |
| Mar2023 | ₹830 Cr | - | |
Compare Total Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,708.5 Cr | 4.7% | 21% | 49.2% | Stock Analytics | |
| SAGILITY | ₹18,552.1 Cr | -1.1% | -2% | -4.9% | Stock Analytics | |
| PRIME FOCUS | ₹18,053.4 Cr | 8.5% | 2.7% | 95.3% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,420.3 Cr | -2.6% | -3.7% | -31.2% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,475.6 Cr | 1.7% | -1.1% | NA | Stock Analytics | |
| INDEGENE | ₹12,364.3 Cr | -2.6% | 0.7% | -8.6% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 4.7% |
21% |
49.2% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses